4.1 Article

Automated matching software for clinical trials eligibility: Measuring efficiency and flexibility

期刊

CONTEMPORARY CLINICAL TRIALS
卷 31, 期 3, 页码 207-217

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cct.2010.03.005

关键词

Clinical trials; Eligibility; Automation

资金

  1. Massey Cancer Center

向作者/读者索取更多资源

Background: Clinical trials (CT) serve as the media that translates clinical research into standards of care. Low or slow recruitment leads to delays in delivery of new therapies to the public. Determination of eligibility in all patients is one of the most important factors to assure unbiased results from the clinical trials process and represents the first step in addressing the issue of under representation and equal access to clinical trials. Methods: This is a pilot project evaluating the efficiency, flexibility, and generalizibility of an automated clinical trials eligibility screening tool across 5 different clinical trials and clinical trial scenarios. Results: There was a substantial total savings during the study period in research staff time spent in evaluating patients for eligibility ranging from 165 h to 1329 h. There was a marked enhancement in efficiency with the automated system for all but one study in the pilot. The ratio of mean staff time required per eligible patient identified ranged from 0.8 to 19.4 for the manual versus the automated process. Conclusion: The results of this study demonstrate that automation offers an opportunity to reduce the burden of the manual processes required for CT eligibility screening and to assure that all patients have an opportunity to be evaluated for participation in clinical trials as appropriate. The automated process greatly reduces the time spent on eligibility screening compared with the traditional manual process by effectively transferring the load of the eligibility assessment process to the computer. (C) 2010 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据